Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes.

Authors
Type
Published Article
Journal
Leukemia & Lymphoma
1029-2403
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
55
Issue
6
Pages
1300–1303
Identifiers
DOI: 10.3109/10428194.2013.834532
PMID: 23952246
Source
Medline
Keywords
  • Myelodysplastic Syndromes
  • Azacitidine
  • Elderly
  • Response
  • Safety

Abstract

Statistics

Seen <100 times